Verrica Pharmaceuticals Long Term Debt

Verrica Pharmaceuticals (VRCA) currently reports a long-term debt of $850K as of June 2026. That compares with $2M in the prior-year period — down 57.1% year over year. Use the charts on this page to explore Verrica Pharmaceuticals's long-term debt history and peer comparisons.

Verrica Pharmaceuticals's long-term debt decreased from $2M to $850K — a 57.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verrica Pharmaceuticals reported $850K in long-term debt as of June 2026. That compares with $2M in the prior-year period — down 57.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $850K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Verrica Pharmaceuticals, and consider following VRCA for alerts when major investors trade the stock.

Verrica Pharmaceuticals is classified in the Healthcare sector. On long-term debt, it currently shows $850K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRCA with unrelated industries.